Wakefield Asset Management LLLP

Position in BMY — Bristol Myers Squibb Co

CIK 1600435 Englewood, CO

Position in BMY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$4,056,678

+$1,548,862 QoQ

Shares Held

70,404

+70.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.24%

of 13F equity value

Holder Rank

#605

of 2,506 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Wakefield Asset Management LLLP holds $8,371,838 across 5 Drug Manufacturers - General names. BMY ranks #1 (48.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co This page	70,404	$4,056,678
2	ABBV	AbbVie Inc.	7,832	$1,970,844
3	MRK	Merck & Co., Inc.	8,331	$1,070,533
4	AMGN	Amgen Inc	2,037	$737,638
5	LLY	ELI LILLY & Co	447	$536,145

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,056,678	70,404	+70.3%	Shares	Defined	2026-08-11
2026-03-31	$2,507,816	41,349	-31.3%	Shares	Defined	2026-05-12
2024-12-31	$3,406,382	60,226	+1256.7%	Shares	Defined	2025-02-05
2022-12-31	$319,386	4,439	-88.7%	Shares	Defined	2023-01-30
2021-03-31	$2,485,996	39,379	+5.9%	Shares	Defined	2021-05-11
2020-12-31	$2,307,019	37,192	-6.0%	Shares	Defined	2021-02-08
2020-09-30	$2,385,916	39,574	-0.5%	Shares	Defined	2020-10-23
2020-06-30	$2,338,887	39,777	-16.5%	Shares	Defined	2020-07-28
2020-03-31	$2,655,063	47,633	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.